Similar results were reported in TRAIL resistant colon cancer cells treated with DuP-697.20 It’s likely that while these small molecules can enhance clustering, concomitant TRAIL binding is necessary to force DR5 into a signaling-competent conformational state. Here, TNFRSF10B is linked to malignant colon neoplasm.